-
ImmunityBio (NASDAQ:IBRX) Given "Buy" Rating at D. Boral Capital
Source: Buzz FX / 01 Mar 2025 07:51:15 America/Chicago
ImmunityBio (NASDAQ:IBRX) Given "Buy" Rating at D. Boral Capital Written by MarketBeat March 1, 2025 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating reaffirmed by analysts at D.
Read more...